<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101044</url>
  </required_header>
  <id_info>
    <org_study_id>2104002974</org_study_id>
    <secondary_id>R34DA053738</secondary_id>
    <nct_id>NCT05101044</nct_id>
  </id_info>
  <brief_title>Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances</brief_title>
  <official_title>Improving Retention in Care for Persons With HIV Who Use Substances by Increasing Acceptance and Reducing Stigma (Open Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The open trial will examine the feasibility and acceptability of a brief,&#xD;
      empirically-supported acceptance-based behavioral therapy intervention to promote retention&#xD;
      in care for out-of-care people with HIV who use substances.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study will adapt a brief, 2-session acceptance-based behavioral therapy (ABBT)&#xD;
      intervention to help people with HIV (PWH) who use substances tolerate fears of&#xD;
      stigmatization, increase acceptance of HIV status and substance use problems, and increase&#xD;
      engagement in care. By conducting an open trial with 15 adults recruited from an HIV primary&#xD;
      medical care clinic, the study will focus on the feasibility of recruiting out-of-care PWH&#xD;
      and determine the acceptability of the refined ABBT protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>An uncontrolled open trial approach will be used in which all participants receive the ABBT intervention.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Client Satisfaction Questionnaire (CSQ)</measure>
    <time_frame>1 month</time_frame>
    <description>The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant Retention Rate Across Intervention Sessions</measure>
    <time_frame>Baseline and 1 month</time_frame>
    <description>The investigators will examine the percent of participants that complete all intervention sessions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Retention Rate for Follow Up Assessments</measure>
    <time_frame>Baseline and 1 month</time_frame>
    <description>The investigators will examine the percent of participants that complete the 1-month follow-up assessment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Substance Use Disorders</condition>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Acceptance-based Behavioral Therapy (ABBT) Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All recruited individuals will receive ABBT intervention. ABBT involves 2 sessions delivered within about a week of each other, consisting of a 20-25 minute session 1, and a 10 minute session 2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Acceptance-based Behavioral Therapy (ABBT) Intervention</intervention_name>
    <description>This acceptance-based behavioral therapy (ABBT) intervention intends to enhance retention in HIV care for people who use substances by targeting stigma. ABBT promotes an accepting stance towards life's challenges and encourages participants to thoughtfully disclose the serostatus and/or substance abuse problems as a behavioral step towards challenging stigmatization fears. The central hypothesis is that increased tolerance of stigmatization, facilitated through increased acceptance of HIV status and substance use behaviors, will increase PWH's longitudinal commitment to care.</description>
    <arm_group_label>Acceptance-based Behavioral Therapy (ABBT) Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. HIV+&#xD;
&#xD;
          2. Meet DSM-5 criteria for one or more of the following substance use disorders, at any&#xD;
             severity level: cocaine, methamphetamine, and/or opioid&#xD;
&#xD;
          3. â‰¥18 years old&#xD;
&#xD;
          4. Poorly retained in care, defined as no attended medical appointment in the past 9&#xD;
             months&#xD;
&#xD;
          5. Able to speak and read English at a level sufficient to complete the study procedures&#xD;
&#xD;
          6. Have telephone access&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        (a) Patients who are cognitively impaired, which will be determined by chart review during&#xD;
        screening&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ethan Moitra, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ethan Moitra, PhD</last_name>
    <phone>(401) 444-1949</phone>
    <email>ethan_moitra@brown.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Megan Pinkston-Camp, PhD</last_name>
    <phone>(401) 793-3582</phone>
    <email>mpinkston@lifespan.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Ethan Moitra</last_name>
      <phone>401-444-1949</phone>
      <email>ethan_moitra@brown.edu</email>
    </contact>
    <investigator>
      <last_name>Ethan Moitra, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acceptance and commitment therapy</keyword>
  <keyword>Acceptance-based behavioral therapy</keyword>
  <keyword>Behavioral intervention</keyword>
  <keyword>Acceptability and feasibility</keyword>
  <keyword>Stigma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

